369 related articles for article (PubMed ID: 23846901)
1. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D.
Chaigne-Delalande B; Li FY; O'Connor GM; Lukacs MJ; Jiang P; Zheng L; Shatzer A; Biancalana M; Pittaluga S; Matthews HF; Jancel TJ; Bleesing JJ; Marsh RA; Kuijpers TW; Nichols KE; Lucas CL; Nagpal S; Mehmet H; Su HC; Cohen JI; Uzel G; Lenardo MJ
Science; 2013 Jul; 341(6142):186-91. PubMed ID: 23846901
[TBL] [Abstract][Full Text] [Related]
2. Magnesium and lymphoma: opportunities in translation.
Van Laecke S; Nagler EV; Vanholder R
Leukemia; 2014 Apr; 28(4):729-31. PubMed ID: 24714345
[No Abstract] [Full Text] [Related]
3. An Update on XMEN Disease.
Ravell JC; Chauvin SD; He T; Lenardo M
J Clin Immunol; 2020 Jul; 40(5):671-681. PubMed ID: 32451662
[TBL] [Abstract][Full Text] [Related]
4. MAGT1-mediated disturbance of Mg
Diao B; Huang X; Guo S; Yang C; Liu G; Chen Y; Wu Y
Sci Rep; 2017 Oct; 7(1):13594. PubMed ID: 29051561
[TBL] [Abstract][Full Text] [Related]
5. MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease.
Brault J; Meis RJ; Li L; Bello E; Liu T; Sweeney CL; Koontz SM; Dowdell K; Theobald N; Lee J; Allen C; Clark AB; Ravell JC; Lenardo MJ; Dahl GA; Malech HL; De Ravin SS
Cytotherapy; 2021 Mar; 23(3):203-210. PubMed ID: 33051095
[TBL] [Abstract][Full Text] [Related]
6. X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia disease: a combined immune deficiency with magnesium defect.
Ravell J; Chaigne-Delalande B; Lenardo M
Curr Opin Pediatr; 2014 Dec; 26(6):713-9. PubMed ID: 25313976
[TBL] [Abstract][Full Text] [Related]
7. Magnesium transporter 1 (MAGT1) deficiency causes selective defects in
Matsuda-Lennikov M; Biancalana M; Zou J; Ravell JC; Zheng L; Kanellopoulou C; Jiang P; Notarangelo G; Jing H; Masutani E; Oler AJ; Olano LR; Schulz BL; Lenardo MJ
J Biol Chem; 2019 Sep; 294(37):13638-13656. PubMed ID: 31337704
[TBL] [Abstract][Full Text] [Related]
8. A Double-Blind, Placebo-Controlled, Crossover Study of Magnesium Supplementation in Patients with XMEN Disease.
Chauvin SD; Price S; Zou J; Hunsberger S; Brofferio A; Matthews H; Similuk M; Rosenzweig SD; Su HC; Cohen JI; Lenardo MJ; Ravell JC
J Clin Immunol; 2022 Jan; 42(1):108-118. PubMed ID: 34655400
[TBL] [Abstract][Full Text] [Related]
9. Lack of NKG2D in MAGT1-deficient patients is caused by hypoglycosylation.
Blommaert E; Cherepanova NA; Staels F; Wilson MP; Gilmore R; Schrijvers R; Jaeken J; Foulquier F; Matthijs G
Hum Genet; 2022 Jul; 141(7):1279-1286. PubMed ID: 35182234
[TBL] [Abstract][Full Text] [Related]
10. Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype.
Klinken EM; Gray PE; Pillay B; Worley L; Edwards ESJ; Payne K; Bennetts B; Hung D; Wood BA; Chan JJ; Marshall GM; Mitchell R; Uzel G; Ma CS; Tangye SG; McLean-Tooke A
J Clin Immunol; 2020 Feb; 40(2):299-309. PubMed ID: 31865525
[TBL] [Abstract][Full Text] [Related]
11. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa Infection Impairs NKG2D-Dependent NK Cell Cytotoxicity through Regulatory T-Cell Activation.
Vourc'h M; David G; Gaborit B; Broquet A; Jacqueline C; Chaumette T; Caillon J; Roquilly A; Retiere C; Asehnoune K
Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32928966
[TBL] [Abstract][Full Text] [Related]
13. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
14. Immunological changes in different patient populations with chronic hepatitis C virus infection.
Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
[TBL] [Abstract][Full Text] [Related]
15. [X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia: report of a family and literature review].
He TY; Xia Y; Li CG; Li CR; Qi ZX; Yang J
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):48-52. PubMed ID: 29342998
[No Abstract] [Full Text] [Related]
16. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
17. Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease.
Ravell JC; Matsuda-Lennikov M; Chauvin SD; Zou J; Biancalana M; Deeb SJ; Price S; Su HC; Notarangelo G; Jiang P; Morawski A; Kanellopoulou C; Binder K; Mukherjee R; Anibal JT; Sellers B; Zheng L; He T; George AB; Pittaluga S; Powers A; Kleiner DE; Kapuria D; Ghany M; Hunsberger S; Cohen JI; Uzel G; Bergerson J; Wolfe L; Toro C; Gahl W; Folio LR; Matthews H; Angelus P; Chinn IK; Orange JS; Trujillo-Vargas CM; Franco JL; Orrego-Arango J; Gutiérrez-Hincapié S; Patel NC; Raymond K; Patiroglu T; Unal E; Karakukcu M; Day AG; Mehta P; Masutani E; De Ravin SS; Malech HL; Altan-Bonnet G; Rao VK; Mann M; Lenardo MJ
J Clin Invest; 2020 Jan; 130(1):507-522. PubMed ID: 31714901
[TBL] [Abstract][Full Text] [Related]
18. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
Huergo-Zapico L; Acebes-Huerta A; Gonzalez-Rodriguez AP; Contesti J; Gonzalez-García E; Payer AR; Villa-Alvarez M; Fernández-Guizán A; López-Soto A; Gonzalez S
PLoS One; 2014; 9(10):e108326. PubMed ID: 25286418
[TBL] [Abstract][Full Text] [Related]
19. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
20. Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD.
Wiesmayr S; Webber SA; Macedo C; Popescu I; Smith L; Luce J; Metes D
Eur J Immunol; 2012 Feb; 42(2):541-50. PubMed ID: 22105417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
